167 related articles for article (PubMed ID: 24988190)
1. Transcutaneous carbon dioxide induces mitochondrial apoptosis and suppresses metastasis of oral squamous cell carcinoma in vivo.
Takeda D; Hasegawa T; Ueha T; Imai Y; Sakakibara A; Minoda M; Kawamoto T; Minamikawa T; Shibuya Y; Akisue T; Sakai Y; Kurosaka M; Komori T
PLoS One; 2014; 9(7):e100530. PubMed ID: 24988190
[TBL] [Abstract][Full Text] [Related]
2. Transcutaneous carbon dioxide suppresses epithelial-mesenchymal transition in oral squamous cell carcinoma.
Iwata E; Hasegawa T; Takeda D; Ueha T; Kawamoto T; Akisue T; Sakai Y; Komori T
Int J Oncol; 2016 Apr; 48(4):1493-8. PubMed ID: 26846904
[TBL] [Abstract][Full Text] [Related]
3. Transcutaneous carbon dioxide enhances the antitumor effect of radiotherapy on oral squamous cell carcinoma.
Iwata E; Hasegawa T; Ueha T; Takeda D; Saito I; Kawamoto T; Akisue T; Sakai Y; Sasaki R; Kuroda R; Komori T
Oncol Rep; 2018 Jul; 40(1):434-442. PubMed ID: 29767262
[TBL] [Abstract][Full Text] [Related]
4. Transcutaneous carbon dioxide application suppresses bone destruction caused by breast cancer metastasis.
Takemori T; Kawamoto T; Ueha T; Toda M; Morishita M; Kamata E; Fukase N; Hara H; Fujiwara S; Niikura T; Kuroda R; Akisue T
Oncol Rep; 2018 Oct; 40(4):2079-2087. PubMed ID: 30066936
[TBL] [Abstract][Full Text] [Related]
5. Reoxygenation using a novel CO2 therapy decreases the metastatic potential of osteosarcoma cells.
Harada R; Kawamoto T; Ueha T; Minoda M; Toda M; Onishi Y; Fukase N; Hara H; Sakai Y; Miwa M; Kuroda R; Kurosaka M; Akisue T
Exp Cell Res; 2013 Aug; 319(13):1988-1997. PubMed ID: 23727023
[TBL] [Abstract][Full Text] [Related]
6. Transcutaneous application of carbon dioxide (CO2) induces mitochondrial apoptosis in human malignant fibrous histiocytoma in vivo.
Onishi Y; Kawamoto T; Ueha T; Kishimoto K; Hara H; Fukase N; Toda M; Harada R; Minoda M; Sakai Y; Miwa M; Kurosaka M; Akisue T
PLoS One; 2012; 7(11):e49189. PubMed ID: 23166610
[TBL] [Abstract][Full Text] [Related]
7. Cepharanthine exerts antitumor activity on oral squamous cell carcinoma cell lines by induction of p27Kip1.
Harada K; Supriatno ; Yamamoto S; Kawaguchi S; Yoshida H; Sato M
Anticancer Res; 2003; 23(2B):1441-8. PubMed ID: 12820407
[TBL] [Abstract][Full Text] [Related]
8. Recombinant canstatin inhibits VEGF-A-induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC-VII animal model.
Hwang-Bo J; Park JH; Bae MG; Chung IS
Cancer Med; 2016 Oct; 5(10):2977-2988. PubMed ID: 27650585
[TBL] [Abstract][Full Text] [Related]
9. Transcutaneous Carbon Dioxide Decreases Immunosuppressive Factors in Squamous Cell Carcinoma In Vivo.
Yatagai N; Hasegawa T; Amano R; Saito I; Arimoto S; Takeda D; Kakei Y; Akashi M
Biomed Res Int; 2021; 2021():5568428. PubMed ID: 34307656
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA induces cell death via Beclin-1-dependent autophagy in oral squamous cell carcinoma SCC-9 cell line.
Qiu Y; Li C; Wang Q; Zeng X; Ji P
Cancer Med; 2018 Feb; 7(2):397-407. PubMed ID: 29316373
[TBL] [Abstract][Full Text] [Related]
11. Arglabin is a plant sesquiterpene lactone that exerts potent anticancer effects on human oral squamous cancer cells via mitochondrial apoptosis and downregulation of the mTOR/PI3K/Akt signaling pathway to inhibit tumor growth in vivo.
He W; Lai R; Lin Q; Huang Y; Wang L
J BUON; 2018; 23(6):1679-1685. PubMed ID: 30610794
[TBL] [Abstract][Full Text] [Related]
12. Physcion 8-O-β-glucopyranoside induces mitochondria-dependent apoptosis of human oral squamous cell carcinoma cells via suppressing survivin expression.
Liu MD; Xiong SJ; Tan F; Liu Y
Acta Pharmacol Sin; 2016 May; 37(5):687-97. PubMed ID: 27063218
[TBL] [Abstract][Full Text] [Related]
13. Transcutaneous carbon dioxide application suppresses the expression of cancer-associated fibroblasts markers in oral squamous cell carcinoma xenograft mouse model.
Tadokoro Y; Takeda D; Murakami A; Yatagai N; Saito I; Arimoto S; Kakei Y; Akashi M; Hasegawa T
PLoS One; 2023; 18(8):e0290357. PubMed ID: 37594996
[TBL] [Abstract][Full Text] [Related]
14. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
[TBL] [Abstract][Full Text] [Related]
15. Eldecalcitol (ED-71), an analog of 1α,25(OH)
Shintani T; Takatsu F; Rosli SNZ; Usui E; Hamada A; Sumi K; Hayashido Y; Toratani S; Okamoto T
In Vitro Cell Dev Biol Anim; 2017 Oct; 53(9):810-817. PubMed ID: 28710602
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of novel HSP90 inhibitor NVP-AUY922 against oral squamous cell carcinoma.
Okui T; Shimo T; Hassan NM; Fukazawa T; Kurio N; Takaoka M; Naomoto Y; Sasaki A
Anticancer Res; 2011 Apr; 31(4):1197-204. PubMed ID: 21508365
[TBL] [Abstract][Full Text] [Related]
17. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
18. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line.
Zhang X; Liu Y; Gilcrease MZ; Yuan XH; Clayman GL; Adler-Storthz K; Chen Z
Cancer; 2002 Oct; 95(8):1663-72. PubMed ID: 12365014
[TBL] [Abstract][Full Text] [Related]
19. Anti-invasion and anti-tumor growth effect of doxycycline treatment for human oral squamous-cell carcinoma--in vitro and in vivo studies.
Shen LC; Chen YK; Lin LM; Shaw SY
Oral Oncol; 2010 Mar; 46(3):178-84. PubMed ID: 20036604
[TBL] [Abstract][Full Text] [Related]
20. Effects of CRM197, a specific inhibitor of HB-EGF, in oral cancer.
Dateoka S; Ohnishi Y; Kakudo K
Med Mol Morphol; 2012 Jun; 45(2):91-7. PubMed ID: 22718294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
